Objectives–Multiple sclerosis (MS) likely results from an interaction between genetic and
exogenous factors. While genetics shapes the overall population MS susceptibility …

Converging evidence implicates immune abnormalities in schizophrenia (SCZ), and recent
genome-wide association studies (GWAS) have identified immune-related single-nucleotide …

PURPOSE: Polycystic ovaries and menstrual disturbances seem to be common among
women taking valproate for epilepsy. The purpose of the present study was to assess the …

Objective To test the hypotheses that blood biomarkers for nervous system injury, serum
concentrations of neurofilament light chain protein (NfL) and glial fibrillary acidic protein …

Introduction The effect of disease-modifying therapies (DMT) on vaccine responses is
largely unknown. Understanding the development of protective immunity is of paramount …

Objectives Oslo, the capital of Norway, has a high prevalence of multiple sclerosis (MS). In
recent decades there has been substantial immigration to Oslo from Asia, the Middle East …

Brainstem regions support vital bodily functions, yet their genetic architectures and
involvement in common brain disorders remain understudied. Here, using imaging-genetics …

Background Fatigue and depression are frequent and often co-occurring symptoms in
multiple sclerosis (MS). Resting-state functional magnetic resonance imaging (rs-fMRI) …

Background Complete recovery after adequately treated neuroborreliosis is common, but
studies report that some patients experience persistent symptoms like self-reported cognitive …

Long-term valproate treatment is associated with polycystic ovaries and endocrine disorders
in women with epilepsy. The mechanisms responsible for these effects are unknown, but …